PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29160134 ↗2017Reported benefit

Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury.

MouseChemical/toxinSprague-DawleyMalen = Pharmacokinetics 105 rats with 35 per group and 5 per time…IntravenousMethylprednisolone 1 mg/kg/day and 0.5 mg/kg/day as targete…Treatment started after establishing the bleomycin acute lung injury model

Model: Acute lung injury by single intratracheal bleomycin injection at 5 mg/kg for pathology, cytokine and lavage studies or 10 mg/kg for the survival study; controls received an equal volume of intratracheal saline

Lung-targeted methylprednisolone liposomes achieved higher lung drug accumulation, peak 30.8 versus 19.2 ug/g for untargeted, better histopathological improvement and lower inflammatory cytokines, and only the 1 mg/kg targeted group showed significantly higher 10-week survival, with no detectable l…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.